CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell 3000 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 USD | -0.85% | +11.13% | +55.32% |
04-15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
04-15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.32% | 324M | |
+6.52% | 71.18B | |
+12.43% | 9.23B | |
-11.55% | 5B | |
+48.05% | 4.46B | |
+5.09% | 3.95B | |
-14.74% | 2.54B | |
+20.00% | 2.44B | |
-24.89% | 2.36B | |
+21.45% | 2.18B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000 Growth Index